Dextrose Monohydrate 10% Injection Shortage Status

Source: FDA · United States

Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Dextrose Monohydrate 10% Injection is currently listed in the FDA database, with all manufacturers reporting availability despite the ongoing status.

What this FDA drug-shortage notice tells you, and what most readers miss

This notice was issued by FDA on April 7, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action, a single localized FDA drug-shortage notice is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.

For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (drug-shortage, fda, medication, Dextrose Monohydrate 10% Injection) map to related alerts in the same area of risk - browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.

What's in Shortage

Generic name: Dextrose Monohydrate 10% Injection Brand name: DEXTROSE Dosage form: Injection Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Other, Pediatric Current status: Current Initial posting date: 03/01/2022 Last updated: 04/02/2026

Which Manufacturers Are Affected

  • Fresenius Kabi USA, LLC: Available. Related info: Check wholesalers for inventory. Presentation: Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76). Contact info: 888-386-1300
  • Baxter Healthcare: Available. Presentation: Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04). Contact info: 888-229-0001
  • Baxter Healthcare: Available. Presentation: Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02). Contact info: 888-229-0001
  • Fresenius Kabi USA, LLC: Available. Related info: Check wholesalers for inventory. Presentation: Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74). Contact info: 888-386-1300
  • Baxter Healthcare: Available. Presentation: Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03). Contact info: 888-229-0001
  • Fresenius Kabi USA, LLC: Available. Related info: Check wholesalers for inventory. Presentation: Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75). Contact info: 888-386-1300

Why There's a Shortage

No specific reason was provided in the source data.

What Patients Should Do

Patients are advised to speak with their pharmacist or healthcare provider to check the latest availability of Dextrose Monohydrate 10% Injection. They can also contact the manufacturer directly for more information. Please remember that patients should consult their healthcare provider for any medical advice and not make changes to their treatment without professional guidance.

Source

Information is attributed to the FDA Drug Shortage Database.

Original source: FDA Official Notice ↗

All Drug Shortages →

Frequently Asked Questions

Common questions about this FDA drug-shortage notice.

What is this FDA drug-shortage notice about?
Dextrose Monohydrate 10% Injection is currently listed in the FDA database, with all manufacturers reporting availability despite the ongoing status.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "low" severity. No immediate action required, but stay aware.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more Drug Shortages updates?
Browse the full Drug Shortages feed on Areazine at areazine.com/drug-shortages/ for the latest updates from FDA and other agencies.